NCT06531707View on ClinicalTrials.gov

Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine

PHASE3RecruitingINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

January 20, 2025

Study Completion Date

February 20, 2025

Conditions
Common Cold
Interventions
DRUG

Ibuprofen + Loratadine fixed dose

Suspension 8,000 mg / 100 mg / 100 mL, 5 mL twice a day

DRUG

Ibuprofen

Suspension 2,000 mg / 100 mL, 20 mL twice a day

DRUG

Loratadine

Suspension 1 mg / 1 mL, 5 mL twice a day

Trial Locations (1)

11000

RECRUITING

Laboratorio Silanes, S.A. de C.V., Mexico City

All Listed Sponsors
lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY